Physician profile
James C Wang
NPI 1588678130
$250,235.83
in general payments reported to CMS, 2019-2025
12 companies · $7,392 in 2025
The $7,392 reported for 2025 was more than what 97% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $27K · 2021: $59K · 2022: $45K · 2023: $15K · 2024: $25K · 2025: $7,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Royalty Or License: $13K · Travel and Lodging: $4,232 · Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,551.49 |
| Royalty Or License | $13,260.00 |
| Travel and Lodging | $4,231.88 |
| Food and Beverage | $1,058.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $137,543.37 | 2019-2025 | Minirail System, Truelok, Truelok System |
| Amdt Holdings, INC. | $56,177.82 | 2019-2023 | Amdt Mini-Rail |
| Nuvasive, INC. | $48,275.53 | 2019-2020 | |
| Arthrex, INC. | $7,088.00 | 2025 | Amdt Mini-Rail |
| Wishbone Medical INC. | $600.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $163.00 | 2021 | |
| Depuy Synthes Sales INC. | $151.90 | 2025 | Hammerlock, Motoband, Dynaforce |
| E.R. Squibb & Sons, L.L.C. | $150.00 | 2023 | Sotyktu |
| Bioventus LLC | $23.50 | 2024 | Exogen Ultrasound Bone Healing System |
| Linvatec Corporation | $23.32 | 2025 | Biobrace 23mm |
| Abbott Laboratories | $23.29 | 2024 | Eterna |
| Novo Nordisk INC | $16.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.